← Cellebrite DI Ltd. CLBT
Market Price
$11.13
Market Cap
$2.69B
P/E Ratio
N/A
Revenue (FY 2025)
↑18.6% YoY
$475.68M
3-Yr CAGR: 20.7%
Net Income
↑127.7% YoY
$78.33M
Net Margin: 16.5%
Free Cash Flow
↑29.7% YoY
$160.32M
FCF Yield: 5.95%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity
Efficiency
16.2%
ROA: 8.3%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (CLBT)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2019 | $171.9M | — | $136.0M | $-1.9M | — | — | — | $16.1M | $9.9M | — |
| FY 2020 | $194.9M | +13.4% | $157.0M | $5.8M | +408.2% | — | — | $66.5M | $60.3M | +507.9% |
| FY 2021 | $246.2M | +26.3% | $203.7M | $71.4M | +1,135.0% | — | — | $36.1M | $30.9M | -48.7% |
| FY 2022 | $270.7M | +9.9% | $219.9M | $120.8M | +69.2% | — | — | $20.6M | $13.7M | -55.8% |
| FY 2023 | $325.1M | +20.1% | $271.9M | $-81.1M | -167.1% | — | — | $102.1M | $96.8M | +607.8% |
| FY 2024 | $401.2M | +23.4% | $338.6M | $-283.0M | -249.0% | — | — | $132.2M | $123.6M | +27.7% |
| FY 2025 | $475.7M | +18.6% | $400.5M | $78.3M | +127.7% | — | — | $173.5M | $160.3M | +29.7% |
Valuation
Market Price
$11.13
Market Cap
$2.69B
Enterprise Value
N/A
P/E Ratio
N/A
P/B Ratio
5.73
FCF Yield
5.95%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
84.20%
Operating Margin
13.98%
Net Margin
16.47%
Return on Equity (ROE)
16.17%
Return on Assets (ROA)
8.34%
Asset Turnover
0.51x
Revenue 3-Yr CAGR
20.68%
Financial Health & Liquidity
Current Ratio
0.05
Cash Ratio
0.34
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$124.46M
Total Debt
N/A
Book Value / Share
$1.94
Cash Flow Efficiency
Operating Cash Flow
$173.54M
Capital Expenditures (CapEx)
$13.22M
Free Cash Flow
$160.32M
OCF / Revenue
36.48%
FCF / Revenue
33.70%
FCF 3-Yr CAGR
127.14%
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
$1.94
EPS YoY Growth
N/A
Balance Sheet (FY 2025)
Total Assets
$938.85M
Total Liabilities
$454.53M
Stockholders' Equity
$484.32M
Current Assets
$19.63M
Current Liabilities
$369.66M